Company Data

Chemomab Therapeutics Ltd.

Ticker
CMMB
Current Price
$1.74 -1.69%
Market Cap
$24.7M
Price Target
Refer to Report
Volume
130.5K
52wk Range
$0.551 - $2.55
Advanced Market Data

Overview

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company’s lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy